Treatment outcomes and risk factors for relapse in patients with early-stage human African trypanosomiasis (HAT) in the Republic of the Congo
OBJECTIVE: In 2002-03, the Republic of the Congo increased the threshold separating stage 1 and 2 cases of human African trypanosomiasis (HAT) from a cerebrospinal fluid (CSF) white cell count of 5 cells/mm³ to 10 cells/mm³. We aimed to assess whether the increased threshold of 10 cells/mm³ is a saf...
Saved in:
Main Authors: | Manica Balasegaram (Author), Steve Harris (Author), Francesco Checchi (Author), Catherine Hamel (Author), Unni Karunakara (Author) |
---|---|
Format: | Book |
Published: |
The World Health Organization,
2006-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Melarsoprol versus eflornithine for treating late-stage Gambian trypanosomiasis in the Republic of the Congo
by: Manica Balasegaram, et al.
Published: (2006) -
Modelling the impact of fexinidazole use on human African trypanosomiasis (HAT) transmission in the Democratic Republic of the Congo.
by: Aatreyee M Das, et al.
Published: (2021) -
Accuracy of five algorithms to diagnose gambiense human African trypanosomiasis.
by: Francesco Checchi, et al.
Published: (2011) -
Prevalence of human African trypanosomiasis in the Democratic Republic of the Congo.
by: Dieudonne Mumba, et al.
Published: (2011) -
Human African trypanosomiasis in the Democratic Republic of the Congo: a looming emergency?
by: Epco Hasker, et al.
Published: (2012)